Ezzati, M., Lopez, A.D., Rodgers, A., Vander Hoorn, S. & Murray, C.J. Selected major risk factors and global and regional burden of disease. Lancet 360, 1347–1360 (2002).
Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).
Li, M.D. The genetics of nicotine dependence. Curr. Psychiatry Rep. 8, 158–164 (2006).
Benowitz, N.L. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am. J. Med. 121, S3–S10 (2008).
Berrettini, W. et al. α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol. Psychiatry 13, 368–373 (2008).
Bierut, L.J. et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16, 24–35 (2007).
Li, M.D. Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum. Genet. 123, 119–131 (2008).
Thorgeirsson, T.E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638–642 (2008).
Caporaso, N. et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 4, e4653 (2009).
Amos, C.I. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616–622 (2008).
Hung, R.J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633–637 (2008).
Pillai, S.G. et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5, e1000421 (2009).
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
Normand, S.L. Meta-analysis: formulating, evaluating, combining, and reporting. Stat. Med. 18, 321–359 (1999).
Thorgeirsson, T. et al. Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42, 448–453 (2010).
Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441–447 (2010).
Falvella, F.S. et al. Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin. Cancer Res. 15, 1837–1842 (2009).
Wang, J.C. et al. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum. Mol. Genet. 18, 3125–3135 (2009).
Wang, J.C. et al. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol. Psychiatry 14, 501–510 (2008).
Schwarz, G. Estimating the dimension of a model. Ann. Stat. 6, 461–464 (1978).
Ioannidis, J.P., Thomas, G. & Daly, M.J. Validating, augmenting and refining genome-wide association signals. Nat. Rev. Genet. 10, 318–329 (2009).
Stirnadel, H. et al. Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis 197, 868–876 (2008).
Firmann, M. et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disord. 8, 6 (2008).
Muglia, P. et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol. Psychiatry published online, doi:10.1038/mp.2008.131 (23 December 2008).
Scott, L.J. et al. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc. Natl. Acad. Sci. USA 106, 7501–7506 (2009).
Chahal, N.S. et al. Ethnicity-related differences in left ventricular function, structure and geometry: a population study of UK Indian Asians and European whites. Heart 96, 466–471 (2009).
Kathiresan, S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334–341 (2009).
Day, N. et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br. J. Cancer 80 (suppl. 1), 95–103 (1999).
Wichmann, H.E., Gieger, C. & Illig, T. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67, S26–S30 (2005).
Wellcome Trust Case-Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
Krawczak, M. et al. PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 9, 55–61 (2006).
John, U. et al. Study of Health in Pomerania (SHIP): a health examination survey in an East German region: objectives and design. Soz. Praventivmed. 46, 186–194 (2001).
Vitart, V. et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437–442 (2008).
McQuillan, R. et al. Runs of homozygosity in European populations. Am. J. Hum. Genet. 83, 359–372 (2008).
Zemunik, T. et al. Genome-wide association study of biochemical traits in Korcula Island, Croatia. Croat. Med. J. 50, 23–33 (2009).
Pilia, G. et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2, e132 (2006).
Li, Y. & Abecasis, G.R. Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am. J. Hum. Genet. S79, 2290 (2006).
de Bakker, P.I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122–R128 (2008).